Dr. Ilana Beth Katz Sand, MD

Dr. Katz Sand practices at Mount Sinai Medical Center in Miami Beach, Florida, part of Mount Sinai Medical Center of Florida.

Dr. Katz Sand's NPI, 1780843722, was assigned on June 5, 2008. Dr. Katz Sand graduated from Columbia University College of Physicians and Surgeons in 2007. Dr. Katz Sand holds New York license 253769.

Dr. Katz Sand's primary practice is Mount Sinai Medical Center, at 4300 Alton Rd, Miami Beach, FL 33140 in Miami-Dade County. The practice phone is (305) 674-2121. Dr. Katz Sand also practices at Mount Sinai Medical Center, 5 E 98th St, New York, NY 10029.

Dr. Katz Sand's primary practice is Mount Sinai Medical Center in Miami Beach, Florida, part of Mount Sinai Medical Center of Florida. Dr. Katz Sand is also affiliated with The Mount Sinai Hospital. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Katz Sand to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Katz Sand practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Katz Sand's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Katz Sand is licensed in New York.

CMS data shows 106 Medicare services from Dr. Katz Sand across 3 procedure codes in 2024, for 25 Medicare patients. Medicare paid $7,427 for them. Every service was in an office.

CMS counts 25 Medicare patients who saw Dr. Katz Sand in 2024. The largest group is under 65, with 14 patients. 48% of them have arthritis. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Katz Sand's median patient age at 47, with 75% women.

In 2024, Dr. Katz Sand wrote 56 Medicare Part D claims for 11 patients. 95% of them were for generic drugs. CMS names the drug for 19 of them, across 1 drug with 11 or more claims each, at $325 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

Dr. Katz Sand accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Katz Sand as offering telehealth.

Dmand AI links 30 papers to Dr. Katz Sand, published from 2014 to 2025. 2018 was the busiest year, with 5. The most frequent topics are Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting and Cognition. Dr. Katz Sand has published most often in Mult Scler. Dr. Katz Sand's most frequent co-authors are Rachel B. Brandstadter, MD, Michelle Therese Fabian, MD and Fred Lublin, MD.

CMS Open Payments shows 10 general payments to Dr. Katz Sand from 5 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $309.

Dr. Katz Sand graduated from Columbia University College of Physicians and Surgeons in 2007.